In Vivo Activity of the Pyrrolopyrazolyl-Substituted Oxazolidinone RWJ-416457

von Hilliard, Jamese J., Fernandez, Jeffrey, Melton, John, Macielag, Mark J., Goldschmidt, Raul, Bush, Karen, Abbanat, Darren
Veröffentlicht 2009

In Vitro Antibacterial Activities of JNJ-Q2, a New Broad-Spectrum Fluoroquinolone

von Morrow, Brian J., He, Wenping, Amsler, Karen M., Foleno, Barbara D., Macielag, Mark J., Lynch, A. Simon, Bush, Karen
Veröffentlicht 2010

Discovery of a Novel Series of Pyridone-Based EP3 Antagonists for the Treatment of Type 2 Diabetes

von Zhang, Xuqing, Zhu, Bin, Guo, Lili, Bakaj, Ivona, Rankin, Matthew, Ho, George, Kauffman, Jack, Lee, Seunghun P., Norquay, Lisa, Macielag, Mark J.
Veröffentlicht in ACS Med Chem Lett (2021)

In Vitro Antibacterial Activity of the Pyrrolopyrazolyl-Substituted Oxazolidinone RWJ-416457

von Foleno, Barbara D., Abbanat, Darren, Goldschmidt, Raul M., Flamm, Robert K., Paget, Steve D., Webb, Glenda C., Wira, Ellyn, Macielag, Mark J., Bush, Karen
Veröffentlicht 2007

Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolution

von Schalk-Hihi, Céline, Schubert, Carsten, Alexander, Richard, Bayoumy, Shariff, Clemente, Jose C, Deckman, Ingrid, DesJarlais, Renee L, Dzordzorme, Keli C, Flores, Christopher M, Grasberger, Bruce, Kranz, James K, Lewandowski, Frank, Liu, Li, Ma, Hongchang, Maguire, Diane, Macielag, Mark J, McDonnell, Mark E, Mezzasalma Haarlander, Tara, Miller, Robyn, Milligan, Cindy, Reynolds, Charles, Kuo, Lawrence C
Veröffentlicht 2011